Last reviewed · How we verify
NCT04186312: ACCESS
A Psychosocial Treatment Program for College Students (ACCESS)
NA trial testing ACCESS - Accessing Campus Connections & Empowering Student Success in Attention Deficit Hyperactivity Disorder in 280 participants. Completed in 15 May 2019.
31 December 2018
Quick facts
| Lead sponsor | University of North Carolina, Greensboro |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Primary purpose | treatment |
| Enrollment | 280 |
| Start date | 1 August 2015 |
| Primary completion | 31 December 2018 |
| Estimated completion | 15 May 2019 |
Drugs / interventions tested
- ACCESS - Accessing Campus Connections & Empowering Student Success
Conditions studied
- Attention Deficit Hyperactivity Disorder — all drugs for Attention Deficit Hyperactivity Disorder →
Sponsor
University of North Carolina, Greensboro
Who can join
Adults 18 to 30, any sex, with Attention Deficit Hyperactivity Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The results of this study are expected to provide important and new information regarding the treatment of academic impairment among college students with ADHD. The present study should provide a substantial addition to the existing knowledge base concerning interventions for college students with ADHD. In addition, because the intervention is being implemented during college, potential benefits include the prevention of the severe academic and psychosocial functioning difficulties associated with ADHD, including school dropout.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04186312
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Attention Deficit Hyperactivity Disorder
Currently open trials in the same condition.
- NCT07001475 — A Study to Test How BI 3031185 is Tolerated by People With Borderline Personality Disorder or Attention-deficit/Hyperact · Phase 1 · recruiting
- NCT06847165 — Trigeminal Nerve Stimulation for Children With Prenatal Alcohol Exposure · NA · recruiting
- NCT06325813 — ADHD PreSMA Response Inhibition Therapy · NA · recruiting
- NCT06248229 — A Trial of Dyanavel XR in Treating Co-occurring Fatigue Symptoms in Adults With Attention Deficit Hyperactivity Disorder · Phase 4 · recruiting
- NCT06232226 — Attention Deficit Hyperactivity Disorder · NA · recruiting
Other University of North Carolina, Greensboro trials
Trials by the same sponsor.
- NCT06921382 — Breastfeeding Intervention to Prevent Obesity Among Children · NA · recruiting
- NCT06364189 — Inspiring Seniors Toward Exercise Promotion · NA · completed
- NCT05454293 — One Talk at a Time: A Racial-ethnic Socialization Intervention for Diverse Families · NA · unknown
- NCT05462977 — Rhythmically Entrained Exercise in Community-Dwelling Older Adults · NA · completed
- NCT05226039 — The Effects of a Single Bout of Aerobic Exercise on Cognition: The Moderating Role of Age · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04186312 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of North Carolina, Greensboro
- Last refreshed: 6 December 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04186312.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing